Posterior transperitoneal robot-assisted partial nephrectomy in the treatment of renal tumors: Feasibility of a hybrid approach.

Chirurgie robotique Néphrectomie partielle Renal mass Retroperitoneal partial nephrectomy Robotic partial nephrectomy Robotic surgery Transperitoneal partial nephrectomy Tumeur du rein

Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 30 11 2021
revised: 01 01 2022
accepted: 10 01 2022
pubmed: 8 2 2022
medline: 3 3 2022
entrez: 7 2 2022
Statut: ppublish

Résumé

Robot-assisted partial nephrectomy (RAPN) for posterior renal tumors may be performed through anterior (transperitoneal) or posterior (retroperitoneal) approach depending on surgeon's expertise. We propose herein a surgical artifice using daVinci Xi system to combine advantages of both approaches. From November 2019 to November 2020, patients with posterior renal mass, candidate for RAPN were prospectively included after informed consent. After positioning patient in lateral position, daVinci Xi system was docked on tumor side, to initiate transperitoneal procedure. Posterolateral dissection of perinephric space along fascia retrorenalis was conducted until psoas major muscle was exposed. Three additional robotic ports were then inserted in lumbar space, and RAPN was resumed after rotating daVinci Xi boom. Demographics, tumor characteristics, perioperative outcomes, estimated glomerular filtration rate (eGFR) and follow-up data were analyzed. Ten consecutive patients underwent RAPN with the modified technique. All cases were performed robotically, without modification of port placement. Median (range) tumor diameter was 37 (21-48mm) with median RENAL score of 8 (4-10) Median operative time and warm ischemia time were respectively 128min (70-180min) and 19min (14-22). One patient had a Clavien-Dindo grade II complication. At median follow-up of 13 months (6-18), all patients had eGFR comparable to baseline. We report the feasibility and safety of a new hybrid posterior transperitoneal approach for RAPN using daVinci Xi system. Limitations include the absence of RENAL score>10 and pT2 tumors. Greater experience is needed to assess learning curve for surgeons untrained to robotic lomboscopy.

Identifiants

pubmed: 35125315
pii: S1166-7087(22)00002-1
doi: 10.1016/j.purol.2022.01.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-225

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Auteurs

M-O Timsit (MO)

Department of urology and transplant surgery, hôpital européen Georges-Pompidou (HEGP), AP-HP, 20, rue Leblanc, 75015 Paris, France; Université de Paris, 45, rue des Saints-Pères, 75006 Paris, France; PARCC INSERM équipe 13, 56, rue Leblanc, 75015 Paris, France. Electronic address: marc-olivier.timsit@aphp.fr.

N Terrier (N)

Department of urology, university hospital of Grenoble, avenue Maquis-du-Grésivaudan, 38700 La Tronche, France. Electronic address: nterrier@chu-grenoble.fr.

T Toinet (T)

Department of urology and transplant surgery, hôpital européen Georges-Pompidou (HEGP), AP-HP, 20, rue Leblanc, 75015 Paris, France; Université de Paris, 45, rue des Saints-Pères, 75006 Paris, France. Electronic address: theodore.toinet@aphp.fr.

C Dariane (C)

Department of urology and transplant surgery, hôpital européen Georges-Pompidou (HEGP), AP-HP, 20, rue Leblanc, 75015 Paris, France; Université de Paris, 45, rue des Saints-Pères, 75006 Paris, France. Electronic address: charles.dariane@aphp.fr.

E Debedde (E)

Department of urology and transplant surgery, hôpital européen Georges-Pompidou (HEGP), AP-HP, 20, rue Leblanc, 75015 Paris, France. Electronic address: debedde.eliott@gmail.com.

F Panthier (F)

Department of urology and transplant surgery, hôpital européen Georges-Pompidou (HEGP), AP-HP, 20, rue Leblanc, 75015 Paris, France; Université de Paris, 45, rue des Saints-Pères, 75006 Paris, France. Electronic address: frederic.panthier@aphp.fr.

N Thiounn (N)

Department of urology and transplant surgery, hôpital européen Georges-Pompidou (HEGP), AP-HP, 20, rue Leblanc, 75015 Paris, France; Université de Paris, 45, rue des Saints-Pères, 75006 Paris, France. Electronic address: nicolas.thiounn@aphp.fr.

F Audenet (F)

Department of urology and transplant surgery, hôpital européen Georges-Pompidou (HEGP), AP-HP, 20, rue Leblanc, 75015 Paris, France; Université de Paris, 45, rue des Saints-Pères, 75006 Paris, France. Electronic address: francois.audenet@aphp.fr.

A Méjean (A)

Department of urology and transplant surgery, hôpital européen Georges-Pompidou (HEGP), AP-HP, 20, rue Leblanc, 75015 Paris, France; Université de Paris, 45, rue des Saints-Pères, 75006 Paris, France. Electronic address: arnaud.mejean@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH